Injury of hypothalamus, enhanced by obesity, disrupts the effects of several metabolic hormones (ghrelin, insulin, leptin, glucagon-like peptide 1 (GLP-1)), which are key regulators of appetite [100]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.